MATERIALISE NV - AMERICAN DEPOSITARY SHARES Action · US57667T1007 · MTLS · A112H0 (XNAS) Belgique · Technology — cotations et cours en temps réel, données d'entreprise, dividendes, fondamentaux et analyse de portefeuille IA sur MoneyPeak

Aperçu

Analyse alimentée par l’IA

Analyse fondamentale

Découvrez ce que disent vraiment les chiffres — avant le marché

Analyser maintenant

Sentiment des actualités

Les actualités d’aujourd’hui sont-elles un signal d’achat ou un avertissement ?

Analyser maintenant

Acheter / Conserver / Vendre

Faut-il acheter, conserver ou vendre ? Obtenez l’avis de l’IA dès maintenant.

Analyser maintenant

Évaluation des risques

Détectez les risques cachés avant qu’ils n’impactent votre portefeuille.

Analyser maintenant

Juste valeur

Cette action est-elle bon marché, correctement valorisée ou surévaluée ?

Analyser maintenant

Dernières analyses d’IA sur MATERIALISE NV - AMERICAN DEPOSITARY SHARES

Pas de cours

31.07.2026 20:00

Cours actuels de MATERIALISE NV - AMERICAN DEPOSITARY SHARES

Bourse	Ticker	Devise	Dernier échange	Cours	Variation journalière
NASDAQ	MTLS	USD	31.07.2026 20:00	6,35 USD	-0,06 USD -0,94 %
IEX	MTLS	USD	31.07.2026 19:59	6,35 USD	-0,06 USD -0,94 %
Hamburg	MNVANS07.HAMB	EUR	31.07.2026 06:37	5,45 EUR	-
Quotrix	MNVANS07.DUSD	EUR	31.07.2026 05:27	5,60 EUR	-
Düsseldorf	MNVANS07.DUSB	EUR	23.07.2026 17:30	5,55 EUR	-

Fonds investis

Les fonds suivants ont investi dans MATERIALISE NV - AMERICAN DEPOSITARY SHARES :

Fonds The 3D Printing ETF	Vol. en millions 21.311,19	Part (%) 3,83 %
Fonds Pacer BioThreat Strategy ETF	Vol. en millions 53,40	Part (%) 1,12 %
Fonds Pacer Military Times Best Employers ETF	Vol. en millions 21,60	Part (%) 1,12 %
Fonds Pacer Salt High truBeta US Market ETF	Vol. en millions 130,71	Part (%) 1,12 %
Fonds Pacer Funds Trust - Pacer Salt Low truBeta US Market ETF	Vol. en millions 69,33	Part (%) 1,12 %

Profil de l'entreprise pour MATERIALISE NV - AMERICAN DEPOSITARY SHARES Action

Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.